Peptide record

TPDB11078

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
29 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11078
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 29-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GFMDTAKNVAKNVAVTLIDKLRCKVTGGC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C131H226N38O39S3
EQHPSWY
KV
3053.65
9.71
5
2
12
+3
0.98
0.228
90.69
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.04
7
Residue Composition
number
3
A
1
R
2
N
2
D
2
C
0
E
0
Q
3
G
0
H
1
I
2
L
4
K
1
M
1
F
0
P
0
S
3
T
0
W
0
Y
4
V
Amino Acid Distribution
A: 3 R: 1 N: 2 D: 2 C: 2 E: 0 Q: 0 G: 3 H: 0 I: 1 L: 2 K: 4 M: 1 F: 1 P: 0 S: 0 T: 3 W: 0 Y: 0 V: 4
Chemical Descriptors
29 reviewed residue count
C131H226N38O39S3 sequence-only estimate (linear, free termini)
3053.65 sequence-only estimate (linear, free termini)
9.71 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
0.98 sequence-only estimate (linear, free termini)
0.228 sequence-only estimate (linear, free termini)
Evidence Records 41 records
Evidence 1 Activity

Activity

MIC
Antibacterial
20 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MI
Evidence 2 Activity

Activity

MIC
Antibacterial
20 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

dbAMP DRAMP

Other

Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25
Evidence 3 Activity

Activity

MIC
Antibacterial
13 µM

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP

Other

12 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25922 (MIC 13 uM), E.coli (IS 37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >
Evidence 4 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

E.cloacae ATCC13047

Source & Reference

dbAMP DRAMP

Other

37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aerugin
Evidence 5 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

K.pneumonia ATCC700603

Source & Reference

dbAMP DRAMP

Other

(MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MI
Evidence 6 Activity

Activity

MIC
Antibacterial
20 µM

Target

B. pyocyaneus CMCCB1010

Source & Reference

dbAMP DRAMP

Other

00 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC
Evidence 7 Activity

Activity

MIC
Antibacterial
50 µM

Target

B. dysenteriae

Source & Reference

dbAMP DRAMP

Other

3 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATC
Evidence 8 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

dbAMP DRAMP

Other

ae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Not
Evidence 9 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

dbAMP DRAMP

Other

(MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Note that the activity of the synthetic v
Evidence 10 Activity

Activity

MIC
Antifungal
20 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MI
Evidence 11 Activity

Activity

MIC
Antifungal
20 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25
Evidence 12 Activity

Activity

MIC
Antifungal
13 µM

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

12 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25922 (MIC 13 uM), E.coli (IS 37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >
Evidence 13 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

E.cloacae ATCC13047

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aerugin
Evidence 14 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

K.pneumonia ATCC700603

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MI
Evidence 15 Activity

Activity

MIC
Antifungal
20 µM

Target

B. pyocyaneus CMCCB1010

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

00 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC
Evidence 16 Activity

Activity

MIC
Antifungal
50 µM

Target

B. dysenteriae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

3 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATC
Evidence 17 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Not
Evidence 18 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Note that the activity of the synthetic v
Evidence 19 Activity

Activity

MIC
Antiparasitic
20 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MI
Evidence 20 Activity

Activity

MIC
Antiparasitic
20 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

DRAMP

Other

Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25
Evidence 21 Activity

Activity

MIC
Antiparasitic
13 µM

Target

Escherichia coli ATCC25922

Source & Reference

DRAMP

Other

12 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25922 (MIC 13 uM), E.coli (IS 37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >
Evidence 22 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

E.cloacae ATCC13047

Source & Reference

DRAMP

Other

37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aerugin
Evidence 23 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

K.pneumonia ATCC700603

Source & Reference

DRAMP

Other

(MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MI
Evidence 24 Activity

Activity

MIC
Antiparasitic
20 µM

Target

B. pyocyaneus CMCCB1010

Source & Reference

DRAMP

Other

00 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC
Evidence 25 Activity

Activity

MIC
Antiparasitic
50 µM

Target

B. dysenteriae

Source & Reference

DRAMP

Other

3 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATC
Evidence 26 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

DRAMP

Other

ae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Not
Evidence 27 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

DRAMP

Other

(MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Note that the activity of the synthetic v
Evidence 28 Activity

Activity

MIC
Antiviral
20 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MI
Evidence 29 Activity

Activity

MIC
Antiviral
20 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

DRAMP

Other

Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25
Evidence 30 Activity

Activity

MIC
Antiviral
13 µM

Target

Escherichia coli ATCC25922

Source & Reference

DRAMP

Other

12 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25922 (MIC 13 uM), E.coli (IS 37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >
Evidence 31 Activity

Activity

MIC
Antiviral
>200 µg/mL

Target

E.cloacae ATCC13047

Source & Reference

DRAMP

Other

37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aerugin
Evidence 32 Activity

Activity

MIC
Antiviral
>200 µg/mL

Target

K.pneumonia ATCC700603

Source & Reference

DRAMP

Other

(MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MI
Evidence 33 Activity

Activity

MIC
Antiviral
20 µM

Target

B. pyocyaneus CMCCB1010

Source & Reference

DRAMP

Other

00 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC
Evidence 34 Activity

Activity

MIC
Antiviral
50 µM

Target

B. dysenteriae

Source & Reference

DRAMP

Other

3 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATC
Evidence 35 Activity

Activity

MIC
Antiviral
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

DRAMP

Other

ae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Not
Evidence 36 Activity

Activity

MIC
Antiviral
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

DRAMP

Other

(MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Note that the activity of the synthetic v
Evidence 37 Activity

Activity

IC50
Hemolysis
135 µM
[Ref:21816202] IC50=135 µM against human and rabbit erythrocytes

Target

human

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
Biochimie. 2012 Feb 94(2):328-334.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 38 Activity

Activity

50% Hemolysis
Toxicity
135 µM
Hemolytic Cytotoxic
50% Hemolysis | 135 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis. | Biochimie | 2012
Evidence 39 Activity

Activity

50% Hemolysis
Toxicity
135 µM
Hemolytic Cytotoxic
50% Hemolysis | 135 | µM | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis. | Biochimie | 2012
Evidence 40 Activity

Activity

IC50
Toxicity
135 µM
Hemolytic Cytotoxic
Hemolytic_activity: [Ref:21816202] IC50=135 µM against human and rabbit erythrocytes | Cytotoxicity: [Ref.21816202] Cytotoxicity: the K562 (IC50=58µM) and HT29 mammalian cell lines(IC50=57µM).

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochimie. 2012 Feb 94(2):328-334.
Evidence 41 Hemolysis

Activity

135 µM
IC50
[Ref:21816202] IC50=135 µM against human and rabbit erythrocytes
Hemolysis

Target

human

Source & Reference

APD_complete HemoPI PD_Hemolysis
Biochimie. 2012 Feb 94(2):328-334.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.